{
    "2021-05-17": [
        [
            {
                "time": "2021-05-17",
                "original_text": "康泰生物新冠疫苗纳入紧急使用！康泰生物的未来怎样看？",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "新冠疫苗",
                        "紧急使用"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-17",
                "original_text": "该公司的一些股东和高管也在减持套现。上述的这些情况也值得投资者关注。",
                "features": {
                    "keywords": [
                        "减持",
                        "股东",
                        "高管"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-05-17",
                "original_text": "康泰生物(300601)公司点评：新冠灭活疫苗纳入紧急使用 有望带来业绩弹性",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "新冠灭活疫苗",
                        "紧急使用",
                        "业绩弹性"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-17",
                "original_text": "中国又一款新冠疫苗获批使用丨医麦猛爆料",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "获批使用",
                        "医麦猛爆料"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-17",
                "original_text": "国内新冠疫苗供不应求状况改变，康泰生物获批紧急使用，2021年其有望将完成蜕变",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "供不应求",
                        "康泰生物",
                        "紧急使用"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-17",
                "original_text": "国产第六款新冠疫苗获批紧急使用",
                "features": {
                    "keywords": [
                        "国产",
                        "新冠疫苗",
                        "紧急使用"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-17",
                "original_text": "东莞证券：康泰生物（300601.SZ）新冠疫苗被纳入紧急使用，维持“谨慎推荐”评级",
                "features": {
                    "keywords": [
                        "东莞证券",
                        "康泰生物",
                        "新冠疫苗",
                        "紧急使用",
                        "谨慎推荐"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-17",
                "original_text": "东吴证券维持康泰生物买入评级：灭活新冠疫苗获得紧急使用，近期有望兑现较大业绩",
                "features": {
                    "keywords": [
                        "东吴证券",
                        "康泰生物",
                        "灭活新冠疫苗",
                        "紧急使用",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}